Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Rönesans Holding finalises funding for Türkiye's major Northern Marmara Motorway Project
-
GREAT AMERICAN MEDIA ANNOUNCES THE MOST SUCCESSFUL FAITH FRANCHISE OF ALL-TIME, 'GOD'S NOT DEAD: IN GOD WE TRUST,' A STREAMING EXCLUSIVE ONLY ON PURE FLIX, NOVEMBER 1
-
Titan International, Inc. Repurchases 8.0 Million Shares from MHR Fund Management
-
Construction Partners, Inc. Enters into Definitive Agreement to Acquire Platform Company in Texas
-
Atlantic Union Bankshares Reports Third Quarter Financial Results
-
Leonard A. Lauder is honored with the Neiman Marcus Award for Distinguished Service in the Field of Fashion
-
Portuguese Transplant Center Analysis of First 100 Cases of Hypothermic Oxygenated PErfusion (HOPE) in Liver Transplantation Demonstrates Increased Use of Marginal Grafts, Making More Livers Available
-
Open Mainframe Project Redefines Developer Experience on the Mainframe with AI and Open Source Community
-
PANERA CELEBRATES GUESTS WITH MYPANERA® WEEK FULL OF VALUE-DRIVEN DEALS
-
Eclipse Zenoh 1.0.0 Debuts, Redefining Connectivity for Robotics and Automotive
-
Investcorp AI Acquisition Corp. Announces Entry into Business Combination Agreement and Scheme Implementation Deed with Bigtincan
-
Atlantic Union Bankshares Corporation Announces Pricing of an Underwritten Offering of 9,859,155 Shares of Common Stock
-
Atlantic Union Bankshares Corporation Announces Agreement to Acquire Sandy Spring Bancorp
-
Cigna Healthcare Commits $600,000 To Reduce Food Insecurity Among Seniors
-
ComplyControl Reveals New Look and Enhanced Services to Drive Innovation in Compliance
-
BeiGene Receives Positive CHMP Opinions for TEVIMBRA® as a First-Line Treatment for Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer and Esophageal Squamous Cell Carcinoma
-
Realta Wealth Continues Leadership Team Expansion, Adds Abbey Eastham As Head of Advisor Relations
-
Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics
-
Nearly 80% of U.S. Adults Say They're Worried About The Economy
-
Tutor Perini Provides Update Regarding Recent Developments
-
Highwoods Declares Quarterly Dividends
-
Endospan Completes Enrollment of Primary Arm in NEXUS® Aortic Arch Stent Graft TRIOMPHE IDE Clinical Study
-
Anaergia’s Organic Waste Receiving Infrastructure for RNG Production to Be Provided to the City of Riverside, California
-
Tower Semiconductor Announces Third Quarter 2024 Financial Results and Conference Call
-
Grab to Announce Third Quarter 2024 Results on November 12, 2024
-
Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers
-
CoachNow by Golf Genius Announces New Low-Cost Membership Option
-
SunHydrogen on Track for 1m² Pilot Demonstration of its Green Hydrogen Panels
-
Nearly 80% of U.S. Adults Say They're Worried About The Economy
-
XO Strengthens World's Largest Private Aviation Network and Boosts Instant Booking Options by Over 55%
-
The FII Institute Unveils Stellar Speaker Lineup and Program Details for FII8 Conference in Riyadh
-
China Eastern Airlines joins 2024 ESG Global Leaders Conference
-
ROSCon 2024: Orbbec Unveils GMSL2/FAKRA Stereo Vision 3D Camera Gemini 335Lg for AMRs and Robotic Arms
-
Q3, 2024
-
Naqdi Takes Over Dubai Metro With Major Sponsorship of World Trade Centre Station
-
Saabsoft Technologies Wins Best Bitrix24 Partner 2023 Award for Vertical Solutions in Real Estate
-
Interim report third quarter 2024: Sandvik
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 18 10 2024] - (CGWL)
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 18 10 2024] - (CGWL)
-
Form 8.3 - [ECKOH PLC - 18 10 2024] - (CGWL)
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc
-
Man Group PLC : Form 8.3 - AngloGold Ashanti plc
-
Genethon to Showcase the Latest Advances in Gene Therapies for Multiple Diseases at the ESGCT 31st Annual Congress October 22 – 25, 2024 in Rome, Italy
-
Form 8.5 (EPT/RI)
-
Net Asset Value(s)
-
Novo Nordisk A/S: Oral semaglutide demonstrates a 14% reduction in risk of major adverse cardiovascular events in adults with type 2 diabetes in the SOUL trial
-
Man Group PLC : Form 8.3 - TI Fluid Systems plc
-
Man Group PLC : Form 8.3 - International Paper Company
-
Debtor distribution data (CK92) - Totalkredit A/S
-
Debtor distribution data (CK92) - Nykredit Realkredit A/S
